NuCana (NCNA) Amortization - Intangibles (2021 - 2024)
NuCana (NCNA) reported Amortization - Intangibles of -$42355.6 for Q4 2024, up 93.22% on a YoY basis from -$21921.4 in Q1 2024, and up 93.22% sequentially from -$624299.4 in Q4 2023.
NuCana (NCNA) Amortization - Intangibles (2021 - 2024) Analysis & Trends
NuCana (NCNA) has 4 years of Amortization - Intangibles data on file, last reported at -$42355.6 in Q4 2024.
- For the quarter ending Q4 2024, Amortization - Intangibles rose 93.22% year-over-year to -$42355.6; the trailing twelve-month figure through Dec 2024 stood at -$4.8 million (changed N/A YoY), and the FY2024 full-year result was -$42183.1, up 93.26% from the prior year.
- Amortization - Intangibles grew to -$42355.6 in Q4 2024, from -$624299.4 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of -$42355.6 in Q4 2024 to a low of -$3.8 million in Q4 2021.
- A 4-year average of -$1.2 million and a median of -$483397.2 in 2023 frame the typical range for Amortization - Intangibles.
- Across the five-year window, Amortization - Intangibles tumbled 82.28% in 2023 and surged 93.22% in 2024, its largest moves.
- Tracing NCNA's Amortization - Intangibles over 4 years: stood at -$3.8 million in 2021, then jumped by 90.95% to -$342495.1 in 2022, then slumped by 82.28% to -$624299.4 in 2023, then surged by 93.22% to -$42355.6 in 2024.
- Business Quant data shows NCNA's Amortization - Intangibles at -$42355.6 in Q4 2024, -$624299.4 in Q4 2023, and -$342495.1 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | NuCana | 14.60 Bn | 14.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -42,355.56 |
| Dec 31, 2023 | -624,299.40 |
| Dec 31, 2022 | -342,495.07 |
| Dec 31, 2021 | -3.79 Mn |